Point72 Hong Kong Ltd - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 99 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$4,000
+300.0%
862
+220.4%
0.00%
Q1 2021$1,000
-85.7%
269
-81.6%
0.00%
Q4 2020$7,000
-92.1%
1,461
-68.7%
0.00%
-100.0%
Q2 2018$89,0004,6700.03%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 3,000,641$29,496,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,308,666$22,694,0000.92%
ArrowMark Colorado Holdings LLC 1,656,422$16,283,0000.16%
IHT Wealth Management, LLC 57,028$561,0000.08%
MOORE CAPITAL MANAGEMENT, LP 50,000$492,0000.02%
Engineers Gate Manager LP 20,264$199,0000.01%
FEDERATED HERMES, INC. 300,000$2,949,0000.01%
FMR LLC 4,048,102$39,793,0000.01%
Invesco Ltd. 1,000,000$9,830,0000.00%
MetLife Investment Management, LLC 14,041$138,0230.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders